Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Buy and Sell Signals, and Other Market Perspectives -- Ignore unavailable to you. Want to Upgrade?

To: GoodGord who wrote (143414)	4/3/2020 1:52:51 PM
From: Hawkmoon	7 Recommendations Recommended By Brian Sullivan GoodGord GROUND ZERO™ Horgad Katelew and 2 more members Read Replies (2) \| Respond to of 222291

In contrast, however, to the Gautret study, eight of the 11 patients had underlying health conditions, and 10 of 11 had fevers and were quite ill at the time the dosing began. It's not a panacea.. It works to SUPPORT the natural immune response by helping to inhibit Viral Replication.. But if the Viral Load is already high, the dosage required will naturally have to be higher, especially in patients with co-morbidities.. Based upon everything I've seen and read, the earlier the better.. Which is why I'm drinking diet tonic water, taking Quercetin, Zinc, and Vitamin C, D3, Magnesium, etc,etc.. And I'll almost guarantee you that there's more hope for the HCQ/Zinc angle than their ever will be for a SAFE vaccine. Not when every past SARS/MERS related vaccine led to the death of the inoculated animals when challenged with the live virus. Hawk